Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration
LONDON, Feb. 28, 2025 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL) (the Company) today announced that it has formally notified The Nasdaq Stock Market LLC (Nasdaq) of its intention to voluntarily delist its American Depositary Shares (ADSs) from Nasdaq and its intent to deregister its ADSs from the Securities and Exchange Commission (SEC) under…








